SCHEMBL9103205

SCHEMBL9103205

CC(C)CC(C(=O)Nc1ccccn1)N1C(=O)Cc2ccc(Cl)cc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 1/20 0.45
S1PR1 P21453 1/20 0.43
S1PR3 Q99500 1/20 0.43
RAB9A P51151 4/20 0.41
NPC1 O15118 3/20 0.41
MITF O75030 1/20 0.41
TP53 P04637 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
XBP1 P17861 1/20 0.41
LMNA P02545 1/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GCK P35557 2/20 0.41
RIPK1 Q13546 1/20 0.40
GRIK1 P39086 1/20 0.40
POLB P06746 1/20 0.40
KCNMA1 Q12791 1/20 0.40
MMP1 P03956 2/20 0.39
MMP3 P08254 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9105915 0.93 FFAR2 (0.45) FFAR2S1PR1S1PR3RAB9ANPC1
SCHEMBL9104726 0.88 LMNA (0.45) FFAR2RAB9ANPC1LMNAALDH1A1
SCHEMBL9908117 0.88 FFAR2 (0.46) FFAR2RAB9ANPC1KDM4EGCK
SCHEMBL9108403 0.88 FFAR2 (0.46) FFAR2RAB9ANPC1KDM4EGCK
SCHEMBL9106250 0.84 GCK (0.51) FFAR2S1PR1S1PR3RAB9ANPC1
SCHEMBL9104313 0.84 RAB9A (0.42) RAB9ANPC1LMNAALDH1A1KDM4E
SCHEMBL9107559 0.83 RAB9A (0.41) RAB9ANPC1LMNAALDH1A1KDM4E
SCHEMBL9908118 0.83 NPC1 (0.47) RAB9ANPC1LMNAALDH1A1KDM4E
SCHEMBL9104263 0.83 FFAR2 (0.47) FFAR2S1PR1S1PR3RAB9ANPC1
SCHEMBL9104553 0.82 GCK (0.58) FFAR2XBP1LMNAGCKKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US claimed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS GPR119, INSR, OAT FFAR2 627/4885S1PR1 3902/4885S1PR3 3734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.